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S U M M A R Y
Listeriosis can be a cause of arthritis. Here, we present a case of Listeria monocytogenes septic arthritis of
the right hip in a 66-year-old male treated with mycophenolate mofetil for polyarteritis nodosa. So far,
septic arthritis due to this microorganism has not been reported in patients treated with mycophenolate
mofetil. We review the literature of L. monocytogenes septic arthritis and discuss the role of
mycophenolate mofetil treatment in precipitating listeriosis.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Listeria monocytogenes is a Gram-positive, facultatively intra-
cellular bacillus that can be isolated from a large number of
environmental sources. It is a relevant pathogen in immunosup-
pressed patients, individuals at the extremes of age, pregnant
women, and occasionally, previously healthy individuals. Menin-
gitis, meningoencephalitis, and bacteremia are the main clinical
manifestations of Listeria infection in immunocompromised hosts,
with an overall mortality as high as 15–30%. L. monocytogenes is the
only Listeria species that infects humans, although rare cases of
human infections with Listeria ivanovii and Listeria grayi have been
reported. Native septic arthritis caused by L. monocytogenes is a
rare event. We present the ﬁrst case of L. monocytogenes septic
arthritis in a patient treated with mycophenolate mofetil for
polyarteritis nodosa. We review the literature of L. monocytogenes
septic arthritis and discuss the role of mycophenolate mofetil
treatment in precipitating listeriosis.* Corresponding author. Tel.: +34 948 255400; fax: +34 948 296500.
E-mail address: jdelpozo@unav.es (J.L. Del Pozo).
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A 66-year-old male patient presenting with a painful right hip
joint was admitted to the orthopedic ward in August 2010. He had
suffered from polyarteritis nodosa since January 2008. He was
initially treated with methotrexate, azathioprine, cyclophospha-
mide, prednisone, inﬂiximab, and rituximab, with no response.
Finally, the treatment was switched to mycophenolate mofetil
(1000 mg twice a day) and corticosteroids in September 2009. The
patient had a partial improvement of his symptoms. He was
receiving trimethoprim–sulfamethoxazole (800/160 mg three
times per week) as antimicrobial prophylaxis.
On January 2010 he stopped trimethoprim–sulfamethoxazole
and calcium because of gastroesophageal reﬂux. At the same time
he started a new diet containing high doses of dairy products and
ﬁsh. In March 2010, he began to experience severe right hip pain
radiating to the knee. A computed tomography scan was
performed revealing a grade 2 avascular necrosis. These ﬁndings
indicated the need for a reduction in the dosage of corticosteroids,
and the mycophenolate mofetil dose was increased to 1500 mg
twice a day. In August 2010, he was admitted to our hospital for
the placement of a prosthetic right hip. No redness or local
elevation of the skin temperature was noted. No fever or
dysthermia was reported. During the procedure, the surgeonses. Published by Elsevier Ltd. All rights reserved.
Table 1
Cases of Listeria septic native arthritis in patients under immunosuppressive therapy
Case Age/sex Affected joint Immunosuppressive
treatment
Listeria
serotype
Treatment Surgery Outcome Ref.
1 64/F Ankle Methotrexate NR Ampicillin and gentamicin NR Cure 6
2 74/F Shoulder and knee Methotrexate and
corticosteroids
NR Ampicillin, clindamycin Yes Cure 3
3 63/M Knee Methotrexate NR Ampicillin NR Cure 2
4 22/F Knee Methotrexate 1/2a Ampicillin, then co-trimoxazole
and rifampin
No Cure 5
5 49/M Knee (bilateral) Corticosteroids NR Penicillin, chloramphenicol and
tetracycline
NR Cure 4
6 65/M Knee Etanercept and
corticosteroids
NR NR No Cure 7
7 54/F Shoulder Etanercept NR Ampicillin Yes Cure 1
F, female; M, male; NR, not reported.
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spacer was placed instead of the prosthesis. After 48 h of culture, a
pure culture of Gram-positive bacteria was observed, and L.
monocytogenes serotype 1/2a was isolated and identiﬁed 72 h
later. The antibiotic treatment that had been initiated at
presentation (ampicillin and levoﬂoxacin) was changed to oral
amoxicillin (1000 mg every 8 h) and trimethoprim–sulfamethox-
azole (800/160 mg every 8 h). Blood cultures remained sterile. He
recovered quickly and rapidly regained mobility of the right hip.
The patient’s condition continued to improve, all blood values
returned to normal, and he was discharged 2 weeks after
admission. He completed an 8-week course of oral amoxicillin
(1000 mg every 8 h) plus trimethoprim–sulfamethoxazole (800/
160 mg every 8 h). Three months later he was successfully
implanted with a prosthetic hip. Intra-operative biopsy cultures
were negative. So far, he has remained on methylprednisolone,
without mycophenolate, with no signs of reactivation of the
infection.
3. Discussion
This report illustrates the ﬁrst described case of septic arthritis
caused by L. monocytogenes in a patient treated with mycophe-
nolate mofetil. A literature review of septic arthritis due to Listeria
has recently been published.1 The authors report 29 cases, most of
them affecting prosthetic joints. It has been speculated that the
presence of a prosthetic joint might increase the likelihood of an
articular Listeria infection.2 We reviewed the literature on Listeria
septic arthritis in native joints in immunocompromised patients
and found seven cases (Table 1). Three patients were male, and the
median patient age was 56 years (range 22–74 years). The knee
was the most frequently affected joint, and two cases involved
more than one joint.3,4,5 Four patients were receiving methotrexate
as immunosuppressive therapy,2,4,6,7 and two patients were
receiving etanercept.2 Outcomes were good for all seven of the
seven patients treated successfully. Two patients needed surgery
to cure the infection.1,3
Mycophenolate mofetil is a selective and reversible inhibitor of
inosine monophosphate dehydrogenase that inhibits the de novopathway of guanosine nucleotide synthesis, necessary for T and B
lymphocyte proliferation. Mycophenolic acid also has a potent
cytostatic effect on lymphocytes, inhibiting the response of
lymphocytes to mitogenic and allospeciﬁc stimulation. It also
suppresses antibody formation by B lymphocytes. It is widely used
to prevent acute rejection in adult solid organ transplant
recipients, and more recently, for the treatment of different
rheumatologic diseases. It has been seen that doses above 2 g per
day may increase the risk of opportunistic infections, as has been
described with cytomegalovirus. Our patient was receiving 3 g a
day. A case with Listeria meningitis during administration of
mycophenolate mofetil for pemphigus vulgaris has also been
described. As with other kinds of immunosuppressive agent,
patients receiving mycophenolate should be aware of the risk of
developing opportunistic infections, such as listeriosis. This is why
we recommend avoiding non-pasteurized dairy products and soft
cheeses during therapy. We also suggest prophylactic treatment
with trimethoprim–sulfamethoxazole. A high index of suspicion
for intracellular infections in patients treated with mycophenolate
mofetil is needed.
Conﬂict of interest: None declared.
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